Matrix metalloproteinase 3 polymorphism: a predictive factor of response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/15102660

Clin. Cancer Res. 2004 Apr 15 10 8 2594-9

Download in:

View as

General Info

PMID
15102660